Discover our CEO’s last publication in the British Journal of Clinical Pharmacology:
In this editorial, we propose the application of the Six Sigma framework to reduce the problem of medication nonadherence, a global epidemic that creates a large impact on health care systems worldwide, due to increased mortality and the economic burden of hospitalization.
https://bpspubs.onlinelibrary.wiley.com/doi/full/10.1111/bcp.13905
Clearly it is in no one’s interests for a clinical trial to fail. Whenever these high-stake activites are abandoned and drug development pathways are aborted, missed opportunities abound. Beyond the sponsor’s missed commercial opportunity, there are missed opportunities to advance
In a clinical trial, every piece of data contributes to the overall story being told. No matter how small or seemingly insignificant, all the information that emerges over the course of the process adds rich detail to the narrative. Two